Pyrazolo[1,5-a][1,3,5]triazin-2-thioxo-4-ones derivatives as thymidine phosphorylase inhibitors: Structure, drug-like calculations and quantitative structure-activity relationships (QSAR) modeling - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Molecular Structure Année : 2020

Pyrazolo[1,5-a][1,3,5]triazin-2-thioxo-4-ones derivatives as thymidine phosphorylase inhibitors: Structure, drug-like calculations and quantitative structure-activity relationships (QSAR) modeling

Résumé

After benchmarks on pyrazolo[1,5-a][1,3,5]triazin-2-thioxo-4-ones, we carried out B3LYP density functional theory computations on the structure and vibrational spectroscopy of a series of twenty-one of its derivatives exhibiting various extent of inhibitory activity against thymidine phosphorylase (TP). Then, we performed drug-like calculations, quantitative structure-activity relationship (QSAR) modeling and an evaluation of the physicochemical properties of this series. In order to design the relationships between molecular descriptors and TP inhibition by pyrazolo[1,5-a][1,3,5]triazin-2-thioxo-4-ones derivatives, we used a multiple linear regression (MLR) procedure. A QSAR model is predicted. A further external set of molecules was used for validation where a high correlation between experimental and predicted activity values is noticed.
Fichier principal
Vignette du fichier
doc00031875.pdf (496.58 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02974009 , version 1 (09-06-2021)

Identifiants

Citer

Marwa Manachou, Zied Gouid, Zineb Almi, Salah Belaidi, Salima Boughdiri, et al.. Pyrazolo[1,5-a][1,3,5]triazin-2-thioxo-4-ones derivatives as thymidine phosphorylase inhibitors: Structure, drug-like calculations and quantitative structure-activity relationships (QSAR) modeling. Journal of Molecular Structure, 2020, 1199, 22p. ⟨10.1016/j.molstruc.2019.127027⟩. ⟨hal-02974009⟩
59 Consultations
58 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More